Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis

Journal of Vascular Surgery

Volumn 49, Issue 3, 2009, Pages 711-718

  Khandanpour, Nader ^a   Willis, Gavin ^a   Meyer, Felicity J ^a   Armon, Matthew P ^a   Loke, Yoon K ^b   Wright, Anthony J A ^c   Finglas, Paul M ^c   Jennings, Barbara A ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b Practice Department   (United Kingdom)

^c INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DATA BASE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; META ANALYSIS; NORFOLK ISLAND; PREVALENCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MUTATION; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PHENOTYPE; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 61549129618     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.10.004     Document Type: Article

References (39)

1. Amputee Statistical Database for the United Kingdom Information Services Division NHS Scotland, 2005. www.nasdab.co.uk Accessed January 7, 2009
2. Hospital Episode Statistics, 2006. www.dh.gov.uk/en/publicationsandstatistics/statistics/hospitalepisodesta tistics/index.htm Accessed January 7, 2009
3. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J Vasc Interv Radiol 17 (2006) 1383-1397 quiz, 1398
4. Archie Jr. J.P. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann Vasc Surg 8 (1994) 475-484
5. Veith F.J., Gupta S.K., Ascer E., White-Flores S., Samson R.H., Scher L.A., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104-114
6. Spark J.I., Laws P., and Fitridge R. The incidence of hyperhomocysteinaemia in vascular patients. Eur J Vasc Endovasc Surg 26 (2003) 558-561
7. Robinson K., Arheart K., Refsum H., Brattstrom L., Boers G., Ueland P., et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 97 (1998) 437-443
8. Bhargava S., Parakh R., Manocha A., Ali A., and Srivastava L.M. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-a-vis occlusive arterial disease. Vascular 15 (2007) 149-153
9. Valentine R.J., Verstraete R., Clagett G.P., and Cohen J.C. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis. Arch Intern Med 160 (2000) 1343-1348
10. Valentine R.J., Guerra R., Stephan P., Scoggins E., Clagett G.P., and Cohen J. Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg 39 (2004) 351-356
11. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202
12. Casas J.P., Bautista L.E., Smeeth L., Sharma P., and Hingorani A.D. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365 (2005) 224-232
13. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
14. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
15. Kang S.S., Zhou J., Wong P.W., Kowalisyn J., and Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43 (1988) 414-421
16. Kang S.S., Wong P.W., Zhou J.M., Sora J., Lessick M., Ruggie N., and Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 37 (1988) 611-613
17. Bailey L.B., and Gregory III J.F. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129 (1999) 919-922
18. Weiss N., Feussner A., Hailer S., Spengel F.A., Keller C., and Wolfram G. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation. Eur J Med Res 4 (1999) 425-432
19. Roe M.A., Heath A.L., Oyston S.L., Macrow C., Hoogewerff J.A., Foxall R., et al. Iron absorption in male C282Y heterozygotes. Am J Clin Nutr 81 (2005) 814-821
20. Higgins J.P.T., and Green S. Cochrane Handbook for Systematic Reviews of Interventions (2008), Wiley-Blackwell, Sussex, UK
21. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi J.M., and Costa F.F. The mutation Ala677->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 77 (1997) 818-821
22. Kibbe M.R., Hassett A.L., McSherry F., Conner P., Bontempo F.A., Williford W., et al. Can screening for genetic markers improve peripheral artery bypass patency?. J Vasc Surg 36 (2002) 1198-1206
23. Mayer O., Filipovsky J., Hromadka M., Svobodova V., Racek J., Mayer Jr. O., et al. Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markers. J Cardiovasc Pharmacol 39 (2002) 851-857
24. Stricker H., Soldati G., Balmelli T., and Mombelli G. Homocysteine, vitamins and gene mutations in peripheral arterial disease. Blood Coagul Fibrinolysis 12 (2001) 469-475
25. Verhoeff B.J., Trip M.D., Prins M.H., Kastelein J.J., and Reitsma P.H. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis. Atherosclerosis 141 (1998) 161-166
26. Rassoul F., Richter V., Janke C., Purschwitz K., Klotzer B., Geisel J., and Herrmann W. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology 51 (2000) 189-196
27. Fowkes F.G., Lee A.J., Hau C.M., Cooke A., Connor J.M., and Lowe G.D. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis 150 (2000) 179-185
28. Ciccarone E., Di Castelnuovo A., Assanelli D., Archetti S., Ruggeri G., Salcuni N., et al. Homocysteine levels are associated with the severity of peripheral arterial disease in Type 2 diabetic patients. J Thromb Haemost 1 (2003) 2540-2547
29. Jones G.T., Harris E.L., Phillips L.V., and van Rij A.M. The methylenetetrahydrofolate reductase C677T polymorphism does not associate with susceptibility to abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 30 (2005) 137-142
30. Mueller T., Marschon R., Dieplinger B., Haidinger D., Gegenhuber A., Poelz W., et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg 41 (2005) 808-815
31. Pollex R.L., Mamakeesick M., Zinman B., Harris S.B., Hanley A.J., and Hegele R.A. Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes. Cardiovasc Diabetol 4 (2005) 17
32. Sofi F., Lari B., Rogolino A., Marcucci R., Pratesi G., Dorigo W., et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 41 (2005) 255-260
33. Balkau B., Vray M., and Eschwege E. Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol 23 Suppl 3 (1994) S8-S16
34. Brattstrom L., Wilcken D.E., Ohrvik J., and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98 (1998) 2520-2526
35. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
36. Little J., Bradley L., Bray M.S., Clyne M., Dorman J., Ellsworth D.L., et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156 (2002) 300-310
37. Trikalinos T.A., Salanti G., Khoury M.J., and Ioannidis J.P. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 163 (2006) 300-309
38. Lucock M. Is folic acid the ultimate functional food component for disease prevention?. BMJ 328 (2004) 211-214
39. Willis G., Walker R., and Jennings B.A. Genetic equilibrium suggests no link between MTHFR and ischaemic heart disease. British Medical Journal eletters 2003. www.bmj.com/cgi/eletters/325/7374/1202#30959 Accessed January 7, 2009